This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

The Feasibility of Simplified Telephone Follow-up After Medical Abortion (SMART)

This study has been completed.
Information provided by (Responsible Party):
University of Pittsburgh Identifier:
First received: February 8, 2008
Last updated: January 27, 2016
Last verified: January 2016
To assess the feasibility of using simplified telephone follow-up to predict pregnancy expulsion after medical abortion, and if in-person follow-up is required to determine the percentage of women that will present for that follow-up.

Condition Intervention
Induced Abortion Other: telephone follow-up

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: The Feasibility of Simplified Telephone Follow-up After Medical Abortion

Further study details as provided by University of Pittsburgh:

Primary Outcome Measures:
  • To determine the rate of completion of telephone interviews after medical abortion, and the rate of return for follow-up if necessary. [ Time Frame: four months ]

Secondary Outcome Measures:
  • To determine if a standardized set of questions can predict pregnancy expulsion, and to determine which method of misoprostol administration women prefer. [ Time Frame: four months ]

Enrollment: 139
Study Start Date: February 2008
Study Completion Date: August 2009
Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: 1
All women undergoing medical abortion will have telephone follow-up approximately one week after using mifepristone and misoprostol.
Other: telephone follow-up
subjects undergoing medical abortion will recieve a telephone call and be asked a series of clinical questions. Expulsion of the pregnancy will be assessed based on the answers to those questions.

Detailed Description:

This is a prospective trial to evaluate the feasibility of performing a telephone interview to predict if pregnancy expulsion has occurred. In those women for whom expulsion has not been predicted to have occurred, the trial will evaluate if they will present for a follow-up visit. We plan to recruit 154 women that desire a medical abortion from Magee-Womens Hospital, Planned Parenthood of Western Pennsylvania, and private offices in the surrounding area. Women who are no more than 63 days gestation will receive mifepristone 200mg and misoprostol 800mcg. Each subject will choose between two evidence-based methods of using the misoprostol: buccally 24-72 hours or vaginally 0-72 hours after mifepristone. A follow-up phone call with a clinician will occur 5-9 days after mifepristone administration. Based on clinical history, including a structured question set, the subject and the clinician will predict if expulsion occurred. If either or both feel that expulsion may not have occurred, the women will return for follow-up in the office within one week for sonographic evaluation. If they both predict that expulsion has occurred at this initial phone call follow-up, the subject will perform a urine pregnancy test at home in approximately 3 weeks. She will have a follow-up phone call after the pregnancy test to obtain the results. The subject will only have an additional visit and ultrasound examination if the urine pregnancy test is positive.

The primary outcome is the percentage of women that will be available for follow-up over the phone, and/or return visit if necessary. The secondary outcomes are to determine if a standardized set of questions of clinical history after medical abortion will be useful to predict expulsion of the pregnancy and which mode of misoprostol administration women prefer. In addition, the study will confirm if women and clinicians are accurate at predicting expulsion of the pregnancy, compare the ability of patients and clinicians to predict expulsion of the pregnancy, determine how many women require follow-up evaluation after a telephone interview, and to determine the pregnancy continuation rate after misoprostol and mifepristone in this study.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • healthy females
  • requesting an elective termination of pregnancy by medical abortion
  • an intrauterine pregnancy </= 63 days gestation
  • willing and able to sign the informed consent
  • willing to comply with the study protocol and visit schedule
  • willing to have a surgical abortion/D&C if indicated
  • with easy and ready access to a telephone

Exclusion Criteria:

  • contraindication to mifepristone
  • contraindication to misoprostol
  • cardiovascular disease -hemoglobin <10 g/dL
  • known clotting defect or receiving anticoagulants
  • pregnancy with an IUD
  • breastfeeding
  • ultrasound evidence of an early pregnancy failure
  • pelvic examination with evidence of acute cervicitis
  • prior participation in this research study
  • current participation in a conflicting research study
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00619658

United States, Pennsylvania
Center for Family Planning Research, Magee-Womens Hospital, University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States, 15213
Sponsors and Collaborators
University of Pittsburgh
Principal Investigator: Lisa K Perriera, MD Center for Family Planning Research, University of Pittsburgh
  More Information

Additional Information:
Responsible Party: University of Pittsburgh Identifier: NCT00619658     History of Changes
Other Study ID Numbers: PRO07080379
Study First Received: February 8, 2008
Last Updated: January 27, 2016

Keywords provided by University of Pittsburgh:
telephone follow-up
medical abortion
induced abortion processed this record on September 21, 2017